{"nct_id":"NCT01726517","title":"Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects","status":"COMPLETED","status_verified_date":"2014-11","start_date":"2012-10","start_date_type":null,"primary_completion_date":"2013-07","primary_completion_date_type":"ACTUAL","completion_date":"2014-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}